Biomarkers were quantified using high-sensitivity immunoassays (MSD, SIMOA Qunaterix).<h4>Results</h4>Astrocyte-derived EVs demonstrated significant enrichment of key AD biomarkers, including Aβ40, Aβ42, and total tau. The gene discussed is MAPT; the disease is Alzheimer disease.